Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Vanda Pharmaceuticals Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
VNDA
Nasdaq
8731
https://www.vandapharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Vanda Pharmaceuticals Inc.
UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer
- Apr 25th, 2024 2:45 pm
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
- Apr 25th, 2024 12:05 pm
Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know
- Apr 24th, 2024 10:00 pm
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
- Apr 24th, 2024 5:58 pm
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZĀ® ANDA Litigation
- Apr 22nd, 2024 11:12 pm
UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
- Apr 22nd, 2024 3:37 pm
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
- Apr 22nd, 2024 2:09 pm
Butler Hall Capital urges Vanda to engage in sales discussions
- Apr 19th, 2024 5:06 pm
Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up
- Apr 18th, 2024 1:44 pm
Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know
- Apr 18th, 2024 1:00 pm
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
- Apr 17th, 2024 6:29 pm
Why Vanda Pharmaceuticals Stock Is Skyrocketing Today
- Apr 17th, 2024 3:53 pm
Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
- Apr 17th, 2024 2:21 pm
Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
- Apr 17th, 2024 1:02 pm
Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors
- Apr 15th, 2024 10:00 pm
Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- Apr 10th, 2024 10:15 pm
AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors
- Apr 8th, 2024 1:21 pm
Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?
- Apr 4th, 2024 11:52 am
Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder
- Apr 3rd, 2024 4:02 pm
Here's Why Amgen (AMGN) Stock is Outperforming the Industry
- Apr 3rd, 2024 3:14 pm
Scroll